Literature DB >> 16306205

Silver-Russell syndrome-like features in a patient carrying a novel NF1 mutation.

Katharina Wimmer1, Mathias Decker, Ertan Mayatepek, Harald Beiglböck, Thomas Eggermann, Hildegard Kehrer-Sawatzki, Christa Fonatsch, Thorsten Rosenbaum.   

Abstract

Mutations in the NF1 gene (17q11.2) cause neurofibromatosis type 1 (NF1), a pleiotropic and progressive autosomal dominant disorder with marked variability of clinical expression. Clinical diagnosis is usually readily achieved in most adult and adolescent patients due to the presence of at least two of the classic signs of NF1. However, the absence of many of the disease-defining features in young children frequently renders definite diagnosis impossible in this age group. Particularly, clinical diagnosis is challenging in young patients whose phenotypical presentation does not lie within the common spectrum of "typical" NF1 features. Sensitive and reliable molecular genetic testing can be of great help in these cases. Here, we report clinical and molecular findings in a 2-year-old boy with features of NF1. Severe growth retardation together with other dysmorphic features was also suggestive for Silver-Russell syndrome (SRS) in this patient. Molecular genetic testing identified a novel NF1 mutation and, thus, enabled a confident NF1 diagnosis despite the unusual phenotypical presentation in this patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306205     DOI: 10.1203/01.pdr.0000183661.81772.f8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  1 in total

1.  One test for all: whole exome sequencing significantly improves the diagnostic yield in growth retarded patients referred for molecular testing for Silver-Russell syndrome.

Authors:  Robert Meyer; Matthias Begemann; Christian Thomas Hübner; Daniela Dey; Alma Kuechler; Magdeldin Elgizouli; Ulrike Schara; Laima Ambrozaityte; Birute Burnyte; Carmen Schröder; Asmaa Kenawy; Peter Kroisel; Stephanie Demuth; Gyorgy Fekete; Thomas Opladen; Miriam Elbracht; Thomas Eggermann
Journal:  Orphanet J Rare Dis       Date:  2021-01-22       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.